The Jasper alternative for Fractional CMOs in Medical Devices & MedTech

What Fractional CMOs in Medical Devices & MedTech need from a marketing platform

A fractional CMO juggles 2–5 clients at once — each with its own brand voice, channels, and KPIs. The bottleneck is execution bandwidth, not strategic clarity. Every hour spent on production is an hour not spent on strategy.

In Medical Devices & MedTech specifically, Fractional CMOs face a compounded constraint: Hospital value analysis committee (VAC) reviews are the primary purchase gate for capital equipment and novel devices — a device that has clinical champion support but fails economic justification (no published cost-effectiveness data, no reimbursement code, no comparable reduction in length of stay) does not get approved. FDA 21 CFR Part 807 (510(k) clearance process); FDA 21 CFR Part 814 (PMA process for Class III devices); FDA Off-Label Promotion prohibition (device labeling and promotion must match cleared indications); Physician Payments Sunshine Act (Open Payments) reporting for physician KOL relationships; Anti-Kickback Statute implications for device incentives; HIPAA for any patient data used in clinical studies; EU MDR (Medical Device Regulation) and IVDR for European device marketing; ISO 13485 quality system certification as marketing credibility signal; GDPR for clinical study and registry data involving EU patients That means needing Medical Devices & MedTech-native execution across Clinical specialty society conferences (ACC, ASN, AAOS, AANS, SAGES, DDW — by clinical specialty), Medical device trade publications (MedCity News, MassDevice, Fierce Medtech, Medical Design & Outsourcing), LinkedIn (CMO or Chief Medical Officer at health systems, OR/cath lab directors, surgeon KOLs, Hospital Value Analysis Coordinator), GPO marketing programs (Vizient, Premier, HealthTrust preferred vendor marketing channels), Clinical society exhibit halls and physician education programs (CME-supported symposia around major meetings) — without adding headcount or managing another tool stack.

Why Fractional CMOs in Medical Devices & MedTech choose Hadrian over Jasper

Marketing teams that need live performance data, paid media agents, attribution, and content working together in one system — the full marketing org, not just the content function.

When Jasper is the right fit: Teams whose primary need is high-volume, brand-safe AI copywriting and content pipelines. Jasper's brand voice governance (Jasper IQ), 900+ enterprise clients, and Forrester-validated ROI make it the safest enterprise content tool available.. Scale your fractional practice without scaling your hours.

Medical Devices & MedTech context Hadrian loads automatically

Medical device marketing that drives adoption requires simultaneous execution on three tracks: clinical evidence (peer-reviewed publications, society presentation abstracts, clinical registry participation), economic justification (published health economic analyses, cost-per-procedure comparisons, length-of-stay impact), and reimbursement support (CPT code coverage, coverage determination letters, payer medical policies). Skipping any track creates a sales ceiling that no campaign can overcome. Sunshine Act-compliant KOL relationship management — where physician education funding and speaking fees are properly documented and reported — is both a compliance requirement and a marketing asset: disclosed, transparent relationships with recognized clinical experts build more credibility than undisclosed ones. Hadrian loads your Medical Devices & MedTech brand profile into every agent run — so Fractional CMOs get industry-native output from day one, without manual configuration.

RELATED